Receptor for advanced glycation end-products and environmental exposure related obstructive airways disease: a systematic review

Eur Respir Rev. 2019 Mar 27;28(151):180096. doi: 10.1183/16000617.0096-2018. Print 2019 Mar 31.

Abstract

Background: Our group has identified the receptor for advanced glycation end-products (RAGE) as a predictor of World Trade Center particulate matter associated lung injury. The aim of this systematic review is to assess the relationship between RAGE and obstructive airways disease secondary to environmental exposure.

Methods: A comprehensive search using PubMed and Embase was performed on January 5, 2018 utilising keywords focusing on environmental exposure, obstructive airways disease and RAGE and was registered with PROSPERO (CRD42018093834). We included original human research studies in English, focusing on pulmonary end-points associated with RAGE and environmental exposure.

Results: A total of 213 studies were identified by the initial search. After removing the duplicates and applying inclusion and exclusion criteria, we screened the titles and abstracts of 61 studies. Finally, 19 full-text articles were included. The exposures discussed in these articles include particulate matter (n=2) and cigarette smoke (n=17).

Conclusion: RAGE is a mediator of inflammation associated end-organ dysfunction such as obstructive airways disease. Soluble RAGE, a decoy receptor, may have a protective effect in some pulmonary processes. Overall, RAGE is biologically relevant in environmental exposure associated lung disease. Future investigations should focus on further understanding the role and therapeutic potential of RAGE in particulate matter exposure associated lung disease.

Publication types

  • Systematic Review

MeSH terms

  • Air Pollutants / adverse effects*
  • Animals
  • Anti-Infective Agents / therapeutic use
  • Biomarkers / metabolism
  • Humans
  • Inhalation Exposure / adverse effects*
  • Lung / drug effects
  • Lung / metabolism*
  • Lung / physiopathology
  • Particulate Matter / adverse effects*
  • Prognosis
  • Pulmonary Disease, Chronic Obstructive / drug therapy
  • Pulmonary Disease, Chronic Obstructive / epidemiology
  • Pulmonary Disease, Chronic Obstructive / metabolism*
  • Pulmonary Disease, Chronic Obstructive / physiopathology
  • Receptor for Advanced Glycation End Products / antagonists & inhibitors
  • Receptor for Advanced Glycation End Products / metabolism*
  • Risk Factors
  • Signal Transduction

Substances

  • AGER protein, human
  • Air Pollutants
  • Anti-Infective Agents
  • Biomarkers
  • Particulate Matter
  • Receptor for Advanced Glycation End Products